ESMO Press Releases

If you require further information regarding any of the press releases listed below, please do not hesitate to contact us (select 'Press & Media').

Filter

Date Title Topic
10 Oct 2016 ESMO 2016 Press Release: MEK Inhibition in KRAS-mutant NSCLC Did Not Improve Survival Lung and other thoracic tumours
10 Oct 2016 ESMO 2016 Press Release: Custirsen Shows no Survival Benefits in Metastatic Prostate Cancer Genitourinary cancers
10 Oct 2016 ESMO 2016 Press Release: Significant Survival Gains from Neoadjuvant Chemotherapy for High-risk Soft Tissue Sarcoma Sarcomas
09 Oct 2016 ESMO 2016 Press Release: First-line Pembrolizumab Plus Chemotherapy Significantly Improves Outcomes in Advanced NSCLC Lung and other thoracic tumours
09 Oct 2016 ESMO 2016 Press Release: Greater Patient Selection May be Needed for First Line Nivolumab to Improve Progression-free Survival in Advanced Lung Cancer Lung and other thoracic tumours
09 Oct 2016 ESMO 2016 Press Release: Significant Survival Gains with Atezolizumab vs Docetaxel for Non-Small-Cell Lung Cancer Head and neck cancers
09 Oct 2016 ESMO 2016 Press Release: Ceritinib Provides Longer Progression-free Survival Than Chemotherapy in Phase III Trial of ALK Rearranged Lung Cancer Treatment Lung and other thoracic tumours
09 Oct 2016 ESMO 2016 Press Release: Nintedanib Improves Progression-free Survival but not Overall Survival in Phase III Trial of Metastatic Colorectal Cancer Gastrointestinal cancers
09 Oct 2016 ESMO 2016 Press Release: Pembrolizumab New Option for First Line Treatment of Patients with Advanced Lung Cancer and High PD-L1 Expression Lung and other thoracic tumours
08 Oct 2016 ESMO 2016 Press Release: True Burden of Head and Neck Cancer in France Underestimated by More Than One-Third Head and neck cancers
08 Oct 2016 ESMO 2016 Press Release: Phase I Study of Novel Anti-Cancer Drug Uses Tumour mRNA Expression to Identify Responders Anticancer agents & Biologic therapy
08 Oct 2016 ESMO 2016 Press Release: Immunotherapy Shows Promising Results in First and Second Line Treatment of Metastatic Bladder Cancer Genitourinary cancers - Anticancer agents & Biologic therapy
08 Oct 2016 ESMO 2016 Press Release: Targeting Estrogen Receptor Improves Progression-free Survival in Advanced Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
07 Oct 2016 ESMO 2016 Press Release: Thousands of Melanoma Patients in Europe Have no Access to New Life Saving Drugs Melanoma
07 Oct 2016 ESMO 2016 Press Release: High response rate in phase I/II paediatric brain cancer trial sets stage for combination therapy with higher response and lower toxicity Central nervous system malignancies